文献速递间质性肺疾病

脂代谢在肺泡蛋白沉积症中的因果作用:观察性与孟德尔随机化研究

Causal role of lipid metabolism in pulmonary alveolar proteinosis: an observational and mendelian randomisation study.
PubMed 文献 · Thorax · 2024-01-18

本研究在确诊肺泡蛋白沉积症(PAP)患者与倾向评分匹配的健康对照中分析临床结局、血脂谱和肺功能,并利用全基因组关联研究数据进行孟德尔随机化与中介分析。观察性结果显示总胆固醇、甘油三酯和低密度脂蛋白(LDL)升高与PAP风险增加相关,LDL升高与PAP风险增加存在因果关联,单核细胞在其中起中介作用,模拟PCSK9抑制与PAP风险降低相关。

要点

  • LDL升高与PAP风险增加存在因果关联(OR 4.32)。
  • 单核细胞升高与PAP风险降低相关并中介LDL的风险效应。
  • 模拟PCSK9抑制与PAP风险降低相关,提示降脂药物靶点潜力。

核心结论

  • 脂代谢相关特征在PAP风险中起重要作用,LDL升高经单核细胞介导对PAP产生因果效应。
  • PCSK9通过升高LDL参与PAP发生发展,降脂药物靶点对PAP具有潜在价值。

研究设计与样本

  • 临床队列分析确诊PAP患者与倾向评分匹配健康对照的临床结局、血脂谱和肺功能。
  • 获取PAP、脂代谢、血细胞及潜在降脂药物靶点基因变异的全基因组关联研究数据,用于孟德尔随机化与中介分析。

主要发现

  • 观察性结果:总胆固醇、甘油三酯和LDL较高与PAP风险增加相关。
  • 总胆固醇和LDL较高与更差的PAP严重程度相关。
  • 孟德尔随机化中LDL升高与PAP风险增加相关(OR 4.32,95%CI 1.63至11.61,p=0.018)。
  • 单核细胞升高与PAP风险降低相关(OR 0.34,95%CI 0.18至0.66,p=0.002),并中介LDL对PAP的风险影响。
  • 模拟PCSK9抑制与PAP风险降低相关(OR 0.03,p=0.007)。

关键数值与推荐

  • LDL升高与PAP风险的孟德尔随机化OR为4.32(95%CI 1.63至11.61,p=0.018)。
  • 单核细胞升高与PAP风险的OR为0.34(95%CI 0.18至0.66,p=0.002)。
  • 模拟PCSK9抑制与PAP风险的OR为0.03(p=0.007)。

临床怎么用

  • 对PAP患者可关注血脂谱尤其是LDL水平,并将其纳入风险评估与随访考量。
  • PCSK9抑制等降脂策略作为PAP潜在治疗方向值得进一步临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary alveolar proteinosis (PAP) is a rare interstitial lung disease characterised by the accumulation of lipoprotein material in the alveoli. Although dyslipidaemia is a prominet feature, the causal effect of lipid traits on PAP remains unclear. This study aimed to explore the role of lipid traits in PAP and evaluate the potential of lipid-lowering drug targets in PAP. METHODS: Clinical outcomes, lipid profiles and lung function tests were analysed in a clinical cohort of diagnosed PAP patients and propensity score-matched healthy controls. Genome-wide association study data on PAP, lipid metabolism, blood cells and variants of genes encoding potential lipid-lowering drug targets were obtained for Mendelian randomisation (MR) and mediation analyses. FINDINGS: Observational results showed that higher levels of total cholesterol (TC), triglycerides and low-density lipoprotein (LDL) were associated with increased risks of PAP. Higher levels of TC and LDL were also associated with worse PAP severity. In MR analysis, elevated LDL was associated with an increased risk of PAP (OR: 4.32, 95% CI: 1.63 to 11.61, p=0.018). Elevated monocytes were associated with a lower risk of PAP (OR 0.34, 95% CI: 0.18 to 0.66, p=0.002) and mediated the risk impact of LDL on PAP. Genetic mimicry of PCSK9 inhibition was associated with a reduced risk of PAP (OR 0.03, p=0.007). INTERPRETATION: Our results support the crucial role of lipid and metabolism-related traits in PAP risk, emphasising the monocyte-mediated, causal effect of elevated LDL in PAP genetics. PCSK9 mediates the development of PAP by raising LDL. These finding provide evidence for lipid-related mechanisms and promising lipid-lowering drug target for PAP.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Huang J, Lin Z, Lin J, et al. Causal role of lipid metabolism in pulmonary alveolar proteinosis: an observational and mendelian randomisation study. Thorax. 2024. PMID: 38124156. doi:10.1136/thorax-2023-220789

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。